MNPR — Monopar Therapeutics Inc. stock price, charts and financials

QT90Monopar Therapeutics Inc.

Monopar Therapeutics Inc. (NASDAQ: MNPR) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
118.46
+6.82+6.11%
OverviewShort InterestFilings
MNPRQT90Monopar Therapeutics Inc.·NASDAQ
118.46+6.11%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 22, 2026S-8 POSS-8 POS
Jul 22, 2026S-8 POSS-8 POS
Jul 22, 20268-KCurrent report
Jul 22, 2026S-8 POSS-8 POS
Jul 22, 2026S-8Registration of employee benefit securities
Jul 22, 2026S-8 POSS-8 POS
Jul 02, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jun 30, 20263Initial statement of beneficial ownership
Jun 30, 20264Statement of changes in beneficial ownership
Jun 30, 20268-KCurrent report
Jun 26, 20268-KCurrent report
Jun 23, 20268-KCurrent report
May 29, 20268-KCurrent report
May 19, 20268-KCurrent report
May 15, 2026SC 13GBeneficial ownership statement (passive)
May 14, 20268-KCurrent report
May 14, 202610-QQuarterly report
May 13, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Apr 30, 2026DEF 14ADefinitive proxy statement
Apr 30, 2026DEFA14AAdditional proxy soliciting materials
Apr 30, 2026ARSAnnual report to shareholders
Apr 20, 20268-KCurrent report
Apr 02, 20264Statement of changes in beneficial ownership
#1 / 25 of 347
Page
▼
/ 14